2,3-bis-(palmitoyloxy)-2-propyl-n-palmitoyl-cysteinylserine has been researched along with Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bousquet, E; Consoli, GM; Galante, E; Geraci, C; Pappalardo, M; Spadaro, A | 1 |
1 other study(ies) available for 2,3-bis-(palmitoyloxy)-2-propyl-n-palmitoyl-cysteinylserine and Neoplasms
Article | Year |
---|---|
Calix[4]arene decorated with four Tn antigen glycomimetic units and P3CS immunoadjuvant: synthesis, characterization, and anticancer immunological evaluation.
Topics: Adjuvants, Immunologic; Animals; Antibodies, Neoplasm; Antigens, Tumor-Associated, Carbohydrate; Calixarenes; Cancer Vaccines; Chromatography, Thin Layer; Dipeptides; Enzyme-Linked Immunosorbent Assay; Female; Immunoglobulin G; Immunotherapy; Indicators and Reagents; Lipoproteins; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred BALB C; Molecular Mimicry; Neoplasms; Phenols; Spectrometry, Mass, Electrospray Ionization | 2008 |